Mechanisms of VEGF (receptor) inhibitors-induced cardiovascular complications

Schematic diagram of the mechanisms of VEGF (receptor) inhibitors-induced cardiovascular complications. Inhibiting the PI3K/Akt pathway causes apoptosis to be activated and ROS to accumulate, which may harm mitochondrial function. Whereas, blocking off-target kinases such as AMPK is linked to disrupting energy homeostasis, decreased cell survival, and a reduced ability to respond to cardiac stress. Each element might have an impact on how HF develops. When it comes to artery thrombosis, the lowered level of PGI2 and NO encourages platelet aggregation, and the level of TXA2 is elevated, which predisposes an individual to ATEs. Furthermore, oxidative stress may result from reduced NO production. Additionally, compromised vascular integrity could root in antiangiogenesis and lead to thrombosis. To sum up, hypertension, cardiac dysfunction, and ATEs are brought on by VEGF (receptor) suppression. AMPK, adenosine 5′-monophosphate-activated protein kinase; ATE, arterial thromboembolic event; NO, nitric oxide; PGI2, prostacyclin; ROS, reactive oxygen species; TKIs, tyrosine kinase inhibitors; TXA2, thromboxane A2; VEGF, vascular endothelial growth factor
Mechanisms of VEGF (receptor) inhibitors-induced cardiovascular complications

Publication

Cardiovascular Complications of Pan-Cancer Therapies: The Need for Cardio-Oncology (2023) Mengjia Chen, et al. Cancers (Basel). 2023 Jun;15(11). Figure: F1.

Gene mentions


Organism Group Word Match Source NCBI Symbol NCBI ID
Homo sapiens Primates VEGF-A VEGFA ncbigene_symbol VEGFA 7422
Homo sapiens Primates VEGF-B VEGFB ncbigene_symbol VEGFB 7423
Homo sapiens Primates VEGF-C VEGFC ncbigene_symbol VEGFC 7424
Homo sapiens Primates VEGF-D VEGF-D ncbigene_synonym VEGFD 2277
Homo sapiens Primates PTK PTK ncbigene_synonym PTK2B 2185
Homo sapiens Primates TK TK famplex_relations TK1 7083
Homo sapiens Primates TK TK famplex_relations TK2 7084
Homo sapiens Primates VEGFR-2 VEGFR2 ncbigene_synonym KDR 3791
Homo sapiens Primates VEGFR-3 VEGFR-3 ncbigene_synonym FLT4 2324
Homo sapiens Primates VEGFR-1 VEGFR-1 ncbigene_synonym FLT1 2321
Homo sapiens Primates PI3K PI3K ncbigene_synonym PIK3CA 5290
Homo sapiens Primates PI3K PI3K ncbigene_synonym PIK3CB 5291
Homo sapiens Primates PI3K PI3K ncbigene_synonym PIK3CD 5293
Homo sapiens Primates PI3K PI3K ncbigene_synonym PIK3CG 5294
Homo sapiens Primates PI3K PI3K famplex_relations PIK3R3 8503
Homo sapiens Primates PI3K PI3K famplex_relations PIK3R4 30849
Homo sapiens Primates PI3K PI3K famplex_relations PIK3R5 23533
Homo sapiens Primates PI3K PI3K famplex_relations PIK3R6 146850
Homo sapiens Primates PI3K PI3K famplex_relations PIK3R1 5295
Homo sapiens Primates PI3K PI3K famplex_relations PIK3R2 5296
Homo sapiens Primates PLCY PLCG famplex_relations PLCG1 5335
Homo sapiens Primates PLCY PLCG famplex_relations PLCG2 5336

Chemical mentions

Word Match MeSH Name ChEBI
Sunitinib sunitinib N-[2-(diethylamino)ethyl]-5-[(Z)-(5-fluoro-2-oxo-1,2-dihydro-3H-indol-3-ylidene)methyl]-2,4-dimethyl-1H-pyrrole-3-carboxamide chebi:38940
Sorafenib sorafenib 4-[4-({[4-chloro-3-(trifluoromethyl)phenyl]carbamoyl}amino)phenoxy]-N-methylpyridine-2-carboxamide chebi:50924
pazopanib pazopanib 5-({4-[(2,3-dimethyl-2H-indazol-6-yl)(methyl)amino]pyrimidin-2-yl}amino)-2-methylbenzenesulfonamide chebi:71219
Axitinib axitinib N-methyl-2-({3-[(E)-2-(pyridin-2-yl)ethenyl]-1H-indazol-6-yl}sulfanyl)benzamide chebi:66910

Disease mentions

Word Match MeSH Name DOID
Hypertension hypertension hypertension DOID:10763